Covid-19: Bharat Biotech scales up manufacturing of Covaxin to support vaccination campaigns

Bharat Biotech on Tuesday announced the Covaxin capacity expansion to support vaccination campaigns in India and worldwide amid the surge in COVID-19 cases. Currently, Hyderabad-based Bharat Biotech is producing 4 million doses of Covaxin a month, while Pune-based Serum Institute of India (SII) is producing 60 million doses of Covishield.